670 related articles for article (PubMed ID: 26178481)
21. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
[TBL] [Abstract][Full Text] [Related]
22. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
23. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
24. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
25. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
26. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
27. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.
Tang R; Ji J; Ding J; Huang J; Gong B; Zhang X; Li F
Cell Cycle; 2020 Jul; 19(13):1602-1610. PubMed ID: 32420813
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma.
Guo XB; Yin HS; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5892-5898. PubMed ID: 30280769
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
31. Expression of FXR and HRG and their clinicopathological significance in benign and malignant pancreatic lesions.
Chen XL; Xie KX; Yang ZL; Yuan LW
Int J Clin Exp Pathol; 2019; 12(6):2111-2120. PubMed ID: 31934033
[TBL] [Abstract][Full Text] [Related]
32. Expression of Frat1 correlates with expression of β-catenin and is associated with a poor clinical outcome in human SCC and AC.
Zhang Y; Han Y; Zheng R; Yu JH; Miao Y; Wang L; Wang EH
Tumour Biol; 2012 Oct; 33(5):1437-44. PubMed ID: 22528942
[TBL] [Abstract][Full Text] [Related]
33. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
34. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
35. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
[TBL] [Abstract][Full Text] [Related]
36. CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas.
Jia N; Dong S; Zhao G; Gao H; Li X; Zhang H
J Cancer Res Ther; 2016; 12(2):892-6. PubMed ID: 27461670
[TBL] [Abstract][Full Text] [Related]
37. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.
Xu YF; Lu Y; Cheng H; Jiang J; Xu J; Long J; Liu L; Ni Q; Liu C; Yu XJ
Curr Mol Med; 2015; 15(4):360-7. PubMed ID: 25829020
[TBL] [Abstract][Full Text] [Related]
38. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
39. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
40. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
